Anti-Human FUNDC2 Antibody
Anti-Human FUNDC2 Antibody with collaborator-tested evidence for IHC. Read more ›
["IHC"]Product Description
FUNDC2 is the stated target for this antibody product. The listing uses collaborator-supplied technical data from Elabscience and is structured for research-use-only antibody selection through ABMIUM.
Product profile: reactivity: Human; host: Rabbit; clonality: Polyclonal; isotype: IgG; available conjugation options: Unconjugated.
Application evidence: Elabscience lists this product for IHC. In the ABMIUM matrix, these listed applications are marked C to show collaborator-tested ABMIUM Verified evidence. Applications not listed in the supplied data remain marked N.
Technical notes: immunogen: Fusion protein of human FUNDC2; purification: Antigen affinity purification; concentration: 1.02 mg/mL.
Database references: UniProt: Q9BWH2 | NCBI Gene: 65991.
Research Use Only.
Key Facts
| Target | FUNDC2 |
| Also known as | Cervical cancer oncogene 3, Cervical cancer proto oncogene 3 protein, DC44, FLJ33773, FUN14 domain containing 2, FUN14 domain containing protein 2, FUNDC 2, HCBP 6, HCBP6, HCC 3, HCC3, Hepatitis C virus core binding protein 6, MGC131676, MGC2495, OTT, OTTHUMP00000015441 |
| Concentration | 1.02 mg/mL |
| Species reactivity | Human |
| Shelf life | 12 months from shipping dates |
| Research area | Epigenetics and Nuclear Signaling, Metabolism, Microbiology, Signal transduction |
| WB | IHC-P | IHC-FR | IF/ICC | FLOW CYT | IP | CHIP | IHC | |
|---|---|---|---|---|---|---|---|---|
| Human |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.